Portal de Periódicos da CAPES

Activated Sulfonamides are Cleaved by Glutathione-S-Transferases

1999; American Society for Pharmacology and Experimental Therapeutics; Volume: 27; Issue: 9 Linguagem: Inglês

10.1016/s0090-9556(24)15015-5

1521-009X

Kenneth A. Koeplinger, Zhiyang Zhao, T. Peterson, Joseph W. Leone, Francis S. Schwende, Robert L. Heinrikson, Alfredo G. Tomasselli,

Genomics, phytochemicals, and oxidative stress

In preclinical pharmacokinetic studies and in in vitro rat, dog, and human primary hepatocyte incubations, the sulfonamide (-NH-SO(2)-) bond of a potent inhibitor of the HIV-1 protease containing the p-cyanopyridinyl moiety (PNU-109112), undergoes metabolic cleavage to form the corresponding amine metabolite (PNU-143070). Strikingly, a compound, PNU-140690, obtained by substituting the cyanopyridinyl group of PNU-109112 with a trifluoropyridinyl moiety, was stable under the same in vivo and in vitro conditions used for PNU-109112. The apparent "sulfonamidase activity" present in liver was localized to the cytosolic fraction and shown to be an enzyme-mediated reaction requiring reduced glutathione (GSH). The enzyme responsible was purified in a single step on a GSH immobilized gel and was identified as glutathione-S-transferase (GST) by sequence analysis of peptides obtained by tryptic digestion of the purified protein. Moreover, a mixture of GST isoenzymes purified from rat liver, and three recombinant human GST isoforms, A1-1, M1-1, and P1-1, were active toward PNU-109112 sulfonamide cleavage; the three isoforms exhibited differential rates of PNU-109112 cleavage, demonstrating isoenzyme selectivity.